Anti-SARS-CoV-2 Revaccination Success in Kidney Transplant Recipients With No Initial Humoral Response Is Linked to Primary Vaccine Type.

Front Med (Lausanne) · 2022 · PMC9289185 · PMID 35860743

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0920

boldest claim

The sentences

borderline non-significantp = 0.06so close (0.05 < p ≤ 0.1)

The T-cellular immune response could only be examined in part in the KTR and borderline non-significant differences were found ( p = 0.06, again in regard to a comparison of all 3-fold vaccine combinations).

also in 434 other papers

a strong trendp = 0.092so close (0.05 < p ≤ 0.1)

Comparing all 3-fold vaccine combinations, however, statistical significance was missed, but a strong trend emerged ( p = 0.092, Table 1 ).

also in 5,725 other papers

borderline significantno p-value reported

Logistic regression revealed that MMF/MPA in the context of immunosuppressive therapy was borderline significant as another predictor of seroconversion after a third mRNA vaccination in KTR.

also in 11,409 other papers

borderline significanceno p-value reported

While this has been described as a predictor of humoral response after the second vaccine dose, we interpret MMF/MPA intake, despite borderline significance, as a predictor of humoral response also to a third vaccine dose.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.